Pricing Log in Create free account
Friday 6 November 2026 Export PBH’s income statement to Excel — free account

Prestige Consumer Healthcare Inc.

PBH Healthcare Drug Manufacturers Specialty & Generic

Prestige Consumer Healthcare Inc.’s revenue for fiscal 2026 (year ended March 2026) was $1.1 billion, down 4.31% from fiscal 2025.

Revenue
+22.7%
EPS
−38.4%
Free cash flow
−38.2%
Total debt
+100.9%

Quarter to September 2026, against a year earlier

44.63 8.65 −16.23%
Market cap
$2.1B
P/E
13.7×
Fwd P/E
11.7×
Dividend yield
—
F-score
5/9
Altman Z
2.48
Beneish M
−2.53
Dividend safety
n/a
Overview
Financials
Income Statement Balance Sheet Cash Flow Metrics & Ratios

Prestige Consumer Healthcare Inc. (PBH) Current ratio

Alert me on Current ratio

Prestige Consumer Healthcare Inc.'s current ratio at the end of the quarter to 30 September 2026 was 2.9×, down 0.6× from fiscal 2026 (3.6×). Over the past ten years it has ranged from 2.0× (fiscal 2015) to 4.2× (fiscal 2025); the current reading is higher than 92% of that period. That is above the Drug Manufacturers Specialty & Generic industry median of 2.4× and below the Healthcare sector median of 3.1×.

Current ratio, annual

Embed this chart

Annual newest first

Period Current ratio Change
FY2026 3.6× (15.14%)
FY2025 4.2× 31.23%
FY2024 3.2× 31.45%
FY2023 2.4× 19.20%
FY2022 2.0× (7.45%)
FY2021 2.2× (9.44%)
FY2020 2.4× 2.94%
FY2019 2.4× (3.79%)
FY2018 2.5× 19.33%
FY2017 2.1× (11.56%)

Quarterly newest first

Period Current ratio Change
Sep 2026 2.9× (9.58%)
Jun 2026 3.2× (9.48%)
Mar 2026 3.6× 14.89%
Dec 2025 3.1× (15.96%)
43 more quarters

Against its own ten years

Low 2.0× High 4.2×
Ten-year median 2.4×
Current reading's percentile 92

Current ratio against peers

Company Current ratio
AMLX Amylyx Pharmaceuticals, Inc. compare 12.1×
RGC Regencell Bioscience Holdings Limited compare 10.8×
HCM HUTCHMED (China) Limited Sponsored ADR compare 5.6×
TRLV Trulieve Cannabis Corp. compare 5.5×
PBH Prestige Consumer Healthcare Inc. 2.9×
BCRX BioCryst Pharmaceuticals, Inc. compare 2.7×
PRGO Perrigo Company plc compare 2.4×
XERS Xeris Biopharma Holdings, Inc. compare 2.2×
ALVO Alvotech compare 1.6×
Drug Manufacturers Specialty & Generic industry median 2.4×
Healthcare sector median 3.1×
Market median 1.6×

What Current ratio is

Current Ratio shows whether a company’s short-term assets are enough to cover the bills and debts it must pay within the next year.

Current Assets (Total) ÷ Current Liabilities (Total)

The full definition of Current ratio →

More on PBH